A Cross-over Trial to Identify Patient Characteristics That Predict Blood Pressure Response to Antihypertensive Therapy in General Practice.

Trial Profile

A Cross-over Trial to Identify Patient Characteristics That Predict Blood Pressure Response to Antihypertensive Therapy in General Practice.

Completed
Phase of Trial: Phase IV

Latest Information Update: 29 Apr 2012

At a glance

  • Drugs Hydrochlorothiazide (Primary) ; Valsartan (Primary)
  • Indications Hypertension
  • Focus Therapeutic Use
  • Acronyms NAMIS
  • Most Recent Events

    • 29 Apr 2012 Results presented at the 22nd European Meeting on Hypertension.
    • 13 Feb 2012 Actual patient number 120 added as reported by ClinicalTrials.gov.
    • 13 Feb 2012 Actual end date Mar 2011 added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top